µÚËľüÒ½´óѧһ¾Å¾Å¶þÄê¹¥¶Á²©Ê¿Ñ§Î»Ñо¿ÉúÈëѧÊÔÌâ ѧ¿Æ×¨Òµ£º g]E>e v{`
QeNN*@
='i
´«È¾²¡Ñ§ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ }>< v7
|.Vs(0O
Ò». Ãû´Ê½âÊÍ(ÿÌâ4·Ö,¹²32·Ö) IAzi:ct
: XaBCF*
1. ICAM-1 "DsL$D2e
q>Kzl/~c.P
2. interleukin 12(IL-12) mq6
TwM
y,cz;2
3. tumor infiltrating lymphocyte &^1{x`Qo=
y';"tD Fb
4. TCR/CD3 complex \_8.\o"@*#
EEdU\9DH(
5. hematopoietin receptor family qEajT"?
83g$k
9lG.
6. individual idiotype(IdI)
GW\66$|
;<N%D=;}@
7. integrin uN+]q qCf
/lDei}
8. colony-stimulatory factor (CSF) C q)Cwc[H
J1g+H2
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© r2G38/K
#bwGDF
1. ÃâÒßÇòµ°°×ÖØÁ´µÄ»ùÒòÈçºÎ½øÐÐÀà±ðת»»(class switching )? SI,
t:=D
(C.<H6]=
2. ¼òÊöɱÉËÐÔTϸ°û(Tc)ɱÉ˲¡¶¾¸ÐȾ°Ðϸ°ûµÄ»úÀí¡£ H7dT6`<~Y
p-XO4Pc6
3. ÉúÎïÓ¦´ðµ÷½Ú¼Á( biological response modifier,BRM)Ö÷ÒªÓÐÄļ¸Àà?¼òÒª½éÉÜÔÚ´«È¾ÐÔ¼²²¡·ÀÖÎÖеÄ×÷Óᣠ4~i?xo=;v
w9TE E,t;5
4. ¼òÊö¿¹ÔÌá³Êϸ°û(APC)Ó븨ÖúÐÔTϸ°û(Th)Ï໥×÷ÓõĹØÏµ¡£ 8e32NJ^k~
3nnoXc'
Èý. ÎÊ´ðÌâ(ÿÌâ18·Ö,¹²36·Ö) $Ts;o
3@42uG>
1. ÊÔÊö¸ÉÈÅËØµÄ·ÖÀ༰ÆäÉúÎïѧ×÷ÓÃÌØµã¡£Ö÷Òª¿ÉÒÔÖÎÁÆÄÄЩ´«È¾ÐÔ¼²²¡?¼òÊö¸ÉÈÅËØ¼ì²âµÄ·½·¨ºÍÔÀí¡£ TyY%<NCIb
53WCF[
2. ºÎΪ»ùÒò¹¤³Ì¿¹Ìå?Ŀǰ¹úÄÚÍâÔÚ»ùÒò¹¤³Ì¿¹ÌåÑо¿ÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? µÚËľüÒ½´óѧһ¾Å¾ÅÈýÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æ×¨Òµ: ´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 1. CD4 2. T cell receptor(TCR) qs!A)H#
n
zU;Bi^m
3. immunoglobulin superfamily (IgSF) ksf6O$
72 ZoN<c
4. selectin fcO|0cQ
:!Nx'F9a
5. anti-idiotypic antibody (¦ÁId) Zc'^iDAY
25 cJA4
6. major histocompatibility complex(MHC) X;n09 L`CB
3Ak'Ue
7. immunotolerance fN/;BT
`<{LW>Lb
8. biological reponse modifier(BRM) %o5'M^U
e_"m\e#N
9. immune reponse gene (Ir gene) ZZ L@UO>:
N<ux4tz
10. reshaped antibody (or reconstituted antibody) \KzH5 ?
:%Oz:YxC/
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© d14 n>
.cHkh^EDY
1. ¼òÊö°×ϸ°û½éËØ6(IL-6)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¡£ k~gOL#$
MB7*AA;
2. ϸ°û¶¾ÐÔTÁܰÍϸ°û(Tc»òCTL)Ó뿹ÌåÒÀÀµµÄϸ°û½éµ¼µÄϸ°û¶¾(ADCC)ɱÉË»úÀíÓкβ»Í¬? TEh.?
_m[DieR
3. ¼òÊöµÚ¢ôÐÍ(³Ù·¢ÐÍ)±ä̬·´Ó¦µÄ·¢Éú»úÀí¡£ DIw_"$'At
*c [^/
4. NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄ±íÃæ±ê¼Ç?NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄÉúÎïѧ»îÐÔ? 0#DEh|?
d$n31F
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö) ¹©´«È¾²¡Ñ§×¨ÒµÊÔÌ⣺ /aMOZ=,q}
A= 5Ebu!z
1. »úÌåÓÐÄÄЩÃâÒßϸ°ûºÍÃâÒß·Ö×Ó²ÎÓ뿹²¡¶¾¸ÐȾ?ËüÃÇÊÇÈçºÎ·¢»Ó²¡¶¾ÃâÒß×÷ÓõÄ? vsZ?cd
#CaPj:>[
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚ²¡¶¾Ñ§ÖÐÓÐÄÄЩÖ÷ÒªÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ ~!5=o{wy
!{(Bc8
hT
¹©Ïû»¯ÄÚ¿Æ×¨ÒµÊÔÌ⣺ XC)9aC@s
Hj|&P/jY]*
1. ĿǰÌåÄÚºÍÌåÍâ¼ì²âÖ×Áö»¼ÕßÃâÒß¹¦Äܵķ½·¨Ö÷ÒªÓÐÄÄЩ?·Ö±ðÐðÊöÿÖÖ·½·¨µÄÔÀíºÍ½á¹û²â¶¨? |Ia9bg'1U
&v0-$
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚÖ×ÁöѧÖÐÓÐÄÄЩÖ÷ÒªµÄÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ z&tC5]#
Lr D@QBT
µÚËľüÒ½´óѧһ¾Å¾ÅËÄÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æ×¨Òµ: HyU: BW;
kuy?n-1g
´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: NBY|U{.g
!T][c~l
̉񧄤 fk5'v
r!?ga
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© G/<zd)
p35=CX`T.
1. CD8 eZa*WI=
,Gt!nm_
2. T cell receptor ¦Á and ¦Â chain (TCR¦Á¦Â ) *9EwZwE_K
nc k/Dw
3. immunoglobulin fold(Ig fold) pT]hPuC
Xb%q9Z
4. cadherin (Ca-dependent cell adhesion moleculers) vn^O m-\
+?{"Q#.>;
5. idiotype-anti-idiotypic antibody immune network theory _-_iw&F
@.eN+o9|
6. HLA class II antigen .*-8rOcc
F?Lt-a+
7. complementarity-determining region (CDR) Vke<; k-
XjG S.&'I
8. perforin(or pore-forming protein ,PFP) !cyrt<
r N$0qo
9. high affinity IL-2 receptor w \b+OW
,eyh%k*hz
10. artificial active immunization eP-|3$
|(>`qL{|
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© }(nT(9|
E!9WZY
1. ¼òÊö°×ϸ°û½éËØ2(IL-2)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¼°ÆäÔÚÁÙ´²ÖÎÁÆÖеÄÓ¦Óá£
}4|EHhG
MGR:IOTa
2. Çë±È½ÏµÚ¢ñÐÍ(ËÙ·¢ÐÍ)³¬Ãô·´Ó¦ÓëµÚ¢ôÐÍ(³Ù·¢ÐÍ)³¬Ãô·´Ó¦µÄ·¢²¡Ìص㡣 cRT'?w`}
>w
S'z]T9
3. ÊÔÊö·ÖÃÚÐÍIgA(secretory IgA)µÄ½á¹¹ÌصãºÍºÏ³É·ÖÃÚ¹ý³Ì¡£ @_+aX.
,
Nz
dN4+
4. ÊԱȽÏT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(Èç±íÃæ¿¹Ô¡¢±íÃæÊÜÌåµÈ)µÄÒìͬµã¡£ YYe G9yR
+RooU?Aq
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö¡£Çë×¢Ò⣺ÿλ¿¼ÉúÖ»ÄÜ´Ó1¡¢2ÌâÖÐѡһÌâ,3¡¢4ÌâÖÐѡһÌâ,¹²´ðÁ½Ìâ,¶à´ðÕß²»¼Æ·Ö¡£) 1. Ŀǰ¼ì²âϸ°ûÒò×ÓÖ÷ÒªÓÐÉúÎïѧ»îÐÔ¼ì²â·¨ºÍÃâÒßѧ¼ì²â·¨,Çë¾ÙÀý·Ö±ðÐðÊöÁ½ÖÖ·½·¨µÄʵÑéÔÀí¡£ z?o8h
N\
E8PDIjp
2. ΪÁ˱ÜÃâIgG¿¹ÌåFc¶Î·ÇÌØÒìÐÔ×÷ÓÃ,³£Ó¦ÓÃθµ°°×øˮ½âµÄF(ab¡¯)2¶Î,ÊÔÎÊÈçºÎÓ¦ÓÃSDS-PAGE·½·¨¶ÔF(ab¡¯)2½øÐмø¶¨? _?~%+Oz/
PgkU~68`
3. ÊÔÊö¿¹Ö×Áö»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ 5XK
Tb
=-U0r$sK+F
4. ÊÔÊö¿¹²¡¶¾»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ ¡¡
enQ*uMKd^
6 s=VU\
µÚËľüÒ½´óѧһ¾Å¾ÅÎåÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ _ ;HdX$op
(0 T!-hsP
ѧ¿Æ×¨Òµ£ºÃâÒßѧ¡¢´«È¾²¡Ñ§¡¢Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿£ºÃâÒßѧ TLwxP"
X*2W4udF
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 'z$N{p40m
rW?Wd
Eg
1. immunoglobulin gene rearrangement
yv,FzF}7
)?rq
8VO
2. the common chain of cytokine receptor (or a cytokine receptor subunit shared by some cytokine receptors) h:4(Gm;
s#X/
F
3. flow cytometry(FCM) <i~xJi%1#
+x%u?ZR
4. carrier effect -@> {q/
!^arWH[od
5. positive selection of T lymphocytes in thymus ob7'''i
o#qdgZ
6. mouse TH1(Th1) and TH2(Th2) subsets Olzw)WjG
7By7F:[ b
7. perforin (pore-forming protein ,PFP) ^6W}ZLp
7@c!4hmrU
8. ADCC(antibody-dependent cell-mediated cytotoxicity) Nc+0_|,
wv\X
9. SH-2(src-homology region 2) :2/L1A)O
k3Yu"GY^
10. Ab2¦Â (internal image) k{vj,#
>2#<gp3
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© kK5&?)3Y:
Cd'D
~'=
1. ½üÄêÀ´ÔÚÈËÀà°×ϸ°û·Ö»¯¿¹Ô(CD)Ñо¿ÁìÓòÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? ILuQ.VhBVN
+yL; ?+s>=
2. ²ÎÓë»î»¯Tϸ°ûÓë»î»¯Bϸ°ûÏ໥×÷ÓõķÖ×ÓÖ÷ÒªÓÐÄÄЩ?¼òÊöÆä½á¹¹ºÍ¹¦ÄÜ? S?v/diK ]J
ZA=J`->k
3. ÊÔÊöHLAÔÚÁÙ´²ÉϵÄÖ÷ÒªÓ¦ÓᣠX;LYGJ{Xk
MZ38=nJ
4. Àý¾ÙÈýÖÖ´ÓÈËÍâÖÜѪµ¥¸öºËϸ°û(PBMC)Öд¿»¯Tϸ°ûµÄ·½·¨,·Ö±ðÐðÊöÆäʵÑéÔÀíºÍÖ÷Òª²Ù×÷²½Öè¡£ aR2N,<Cp5
!gI0"p?
5. ÆÀ¼Ûºìϸ°ûÉú³ÉËØ(EPO)¡¢¸ÉÈÅËØ(IFN)ºÍ¼¯Âä´Ì¼¤Òò×Ó(CSF)ÔÚÁÙ´²Ä³Ð©¼²²¡µÄÓ¦ÓᣠD5"5`w=C
5 3pW:`
Èý. Ñ¡ÔñÎÊ´ðÌâ(ÿÌâ10·Ö,¹²20·Ö¡£Çë°´±¨¿¼×¨Òµ´ðÌâ,Èç´ð·Ç±¾×¨ÒµÌâ»ò¶à´ðÌâ¾ùÊÓΪÎÞЧ¡£) ZvyZ5UA
Lv+{@)
ÃâÒßѧרҵ£º V_3oAu54s{
6vNW)1{nn
1. ÊÔÊöϸ°ûÒò×ÓÊÜÌåÖÐ,Ig³¬¼Ò×å¡¢ÔìѪÒò×ÓÊÜÌ峬¼Ò×å¡¢Éñ¾Éú³¤Òò×ÓÊÜÌ峬¼Ò×åÒÔ¼°Ç÷»¯Òò×ÓÊÜÌ峬¼Ò×åµÄÖ÷Òª½á¹¹Ìصã,ÿ¸ö³¬¼Ò×åÀý¾Ù³ö2¸ö³ÉÔ±¡£ ")8l'^Mq2
q%,86A>
2. ÊԱȽÏÈËT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(±íÃæ±ê¼Ç)µÄÒìͬµã,ËüÃÇ·Ö±ð²ÎÓëÄÄЩÖ÷ÒªµÄÃâÒß¹¦ÄÜ? NFVu~t
-O &>HA
´«È¾²¡Ñ§×¨Òµ£º pCkMm)2g!
U_
VP\ 03
1. ÈËÀàÃâÒßȱÏݲ¡¶¾(HIV)¸ÐȾÈËÌåºó,ÃâÒß¹¦Äܿɷ¢ÉúÄÄЩÖ÷ÒªµÄ±ä»¯?»úÀíÊÇʲô?ÈçºÎ½øÐÐÏàÓ¦µÄÃâÒßѧ¹¦Äܼì²â£¿ Nd(3q]{
.7.1JT#@A7
2. ÇëÆÀÊöÉö×ÛºÏÕ÷³öѪÈȲ¡¶¾(HFRSV)¸ÐȾºó»úÌåÃâÒßѧ±ä»¯µÄÓ벡ÀíËðÉ˵ĹØÏµ¡£ KY&Lv^1_|
7bYwh8
Ïû»¯×¨Òµ£º 2:Yvr_L
aUL7]'q}
1.ÊÔÊöÓëÏû»¯ÏµÍ³ÓйصÄÖ×ÁöÏà¹Ø¿¹ÔÑо¿µÄ½øÕ¹¡£ E$lbm>jsb$
XrUI[ryE
2.¼òÊöճĤÏà¹ØÁܰÍÑù×éÖ¯(mucosal assiociated lymphoid tissue,MALT)µÄ×é³ÉºÍ¹¦ÄÜÌØµã¡£·ÖÃÚÐÍIgAÊÇÈçºÎ½øÐкϳɺͷÖÃÚµÄ? Zf>:h
#;99vw
c
µÚËľüÒ½´óѧһ¾Å¾ÅÁùÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ÃâÒßѧÊÔÌâ O+&;,R:
`Fcr`[
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© `BZ|[
q3
pk u\)
1. Fas(CD95)/FasL =WUNBav
BoT#b^l
2. common chain of cytokine receptor !{,2uQXe
NcbW"Qv3
3 . TCR/CD3 complex 8nZ_.
T0A=vh;S
4. negaive selection of thymocytes 0]f/5
jvLj
w
nBvJb]4l
5. artificial active immune N5W!(h)
Wlg 1t~1=
6. anti-idiotypic v~
x`a0
{|$kI`h,3-
7. IgSF A1;'S<a
x _kT
Wq
8. Integrin 9e.v[K~
t"9r`0>
9. chemokine {oAD;m`
tSni[,4Kq
10. B7/CD28 )"
Z|x
"*HEXru#B
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£© ;9#%E
'I}wN5`
1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£ >bI\pJ
t(vyi
2. ±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã¡£ +t-_FbFh3D
>`[+24e
3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ =oq= ``%
K[?@nl?,z
4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆÊµÑé·½°¸¿Ë¡´Ë»ùÒò¡£ 2^=.f?_YR
eC<?g
5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£ YADXXQ"
xY.?OHgG/
µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ f`rI]v|@
6~>h;wC
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© uT=5
zu
ugj I$u
1. B7/CD28 )p#L "r^)
e\-,e+
2. Th1 subset 1fM`n5?"
y,OG9iD:h
3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£© |#BN!kc
l+wfP76w
4. antibody affinity maturation 6Z=Qs=q
]Nssn\X7
5. AP-1 QX&Y6CC`]
xzFQ)t&
6. single chain variable fragment£¨ScFv£© PRBlf
rXBCM
7. NK cell receptor 6kAGOjO
}7xcHVO8-
8. Zinkernagel-Doherty phenomenon &v;o }Q}E{
$Xu/P5
9. Ig fold bI(8Um6m
s +qodb+
10. CD40/CD40L paMK]-
2}*8( 32
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£© f+1'Ah0'E
Z.x]6
1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØÏµ¡£ u]`0QxvZ
C(8!("tU
2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿ u
i$4
rQ2TPX<?a
3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹ØÏµ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿ L`wr~E2u
t.
(6tL]
Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩
B[#n,ay
"3a}~J<g
1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁܰÍϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£ -okq=9
bC) <K/Q9
2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£ }s6Veosl
e"{"g[b/7
3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æ×¨Òµ£©¡£ SkCux
!;d>}iE
Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ £¨ÃâÒßѧרҵºÍרҵ»ù´¡£© 8Z"f"
_% \%
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© WB<MU:.Vc
W! Hn`T
1.Co-stimulators (or co-stimulating molecules) @t*D<B$
$e,r>tgD
2.NK-kB NpKyrXDJv
JL{fW>5y|
3.Immunoglobulin superfamily esQ`6i
.c @Y?..+
4.antigen-presenting cell (APC) kg7bZ
F+ RE
5.death domain X=lsuKREZ
0S'@(p[A
6.CCR and CXCR ue@W@pj
:xbj&
l
7.Lectin (or mitogen) ;volBfv
:=5X)10
8.Clusters of differentiation, CD) EA9
.?F
\7#w@3*
9.B7 family ?$uF(>LD
3;wiwN'
10.Cytotoxic T lymphocyte, CTL) [u^ fy<jdp
!>=lah$&
11.IL-15 and IL-15 receptor (IL-15R) q8;MPXSG3
C+jXH)|iq
12.MHC restriction %6Vb1?x
c#1kg@q@
13.Affinity-chromatography ) j&khHD
*tk=D sRW
14.Cyctosprin A, CsA a~Ld
cUYs
@p}_"BHYWt
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) a#[gNT~[
!<VP[%2L~
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© Ea'jAIFPpO
05\0g9
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 `
"-P g5
n9k
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ &)JoB
S')DAx
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ + @|u
8+
r!eW]M
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© 1>Vq<z
T /IX(b'<
ÃâÒßѧרҵ£º ;lrO?sm
br
3-.g
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ &m[}%e%~0
Mqk|H~l5c
Ïû»¯ÄÚ¿Æ£º 2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ %6^nb'l'C
x?u@
j7[
ѪҺ²¡Ñ§×¨Òµ£º 3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿ 9^N(s7s
) R5j?6}xF
Ò»¾Å¾ÅÄê¾Å²©Ê¿ÉúÈëѧ¿¼ÊÔÊÔÌâ (רҵ»ù´¡: ÃâÒßѧ) *=v%($~PK6
MZcvr 9y
Ò».Ãû´Ê½âÊÍ(ÿÌâ5·Ö,¹²45·Ö) ips)-1
V
EsM
1. ADCC(antibody dependent cell-mediated cytotoxicity) 3XQe? 2:<
1q5S"=+W[
2. »·æß¾úËØ(cyclosporin) ht>/7.p]
)b=vBs`%
3. KIR(killer cell inhibitory receptor) nR@mm
j
8\:>;XG6f
4. HLDA(human leucocyte differentiation antigen) _y>d
rvg
!TY0;is
5. Interleukin 18(IL-18) 0pW;H|h
1|ddG010
6. ÕûºÏËØ(integrin) (4yXr|to}
+t&)Z
7. Fas/FasL vkR~nIp
'Z9UqEGV
8. FcR(ÃâÒßÇòµ°°×Fc¶ÎÊÜÌå) kRb JK
@icw:68
9. ϸ°û¼äÕ³¸½·Ö×Ó(ICAM) I5g|)Y Q
Knb(MI6
10. Th1/Th2 1uG)U)y/Q
`U\l: ~]e
11. »ùÒòÒßÃç(DNAÒßÃç) Z,O-P9jC
dBovcc
12. chemokines and chemokine receptor L ed{#+
AS~!YR
13. ÃâÒßÄÍÊÜ :
)B1|1
s?->2gxhx
14. ¹²´Ì¼¤·Ö×Ó 8@S]P0lk
ZPq.|6&
15. ËÀÍö½á¹¹Óò(death domain) ;/?w-)n?
!T
,=kh
¶þ.ÎÊ´ðÌâ(µÚ1¡¢2Ìâ¸÷18·Ö,µÚ3Ìâ19·Ö) ev+H{5W8
VnB HQ.C
1. ÊԱȽÏɱÉËÐÔTϸ°û(CTL)Óë×ÔȻɱÉËϸ°û(NK)ÔÚɱÉ˰Ðϸ°û¹ý³ÌÖÐ,ʶ±ðϸ°û¶¾¼°½éµ¼ÃâÒß¹¦ÄÜÓкβ»Í¬? e 6>j
gy
R~[~(`/S
2. 70Äê´úÒÔÀ´,ÓйØIgºÍÌåÒºÃâÒßÑо¿´æÔÚÒÔϼ¸ÏîÖØ´ó·¢ÏÖºÍÍ»ÆÆ¶ø»ñµÃҽѧºÍÉúÎïѧŵ±´¶û½±,Çë·Ö±ð²ûÊöËüÃǵÄÀíÂÛÒâÒå¼°ÔÚҽѧʵ¼ùÖеÄÓ¦Óᣠ}opMf6`w
k&f/f
£¨1£©1972Ä꣺θµ°°×øºÍľ¹Ïµ°°×øˮ½âIg£¬»ñµÃFab¡¢Fc¡¢F£¨ab¡¯£©2µÈƬ¶Î ,mi
7WW9
83'+q((<
£¨2£©1977Ä꣺·ÅÉäÃâÒß·¨ (0`w.n
jJt4{c
£¨3£©1984Ä꣺ÁܰÍϸ°ûÔÓ½»ÁöºÍµ¥¿Ë¡¿¹Ìå L,nb<
8d Fqwpw8
£¨4£©1987Äê: Ig»ùÒòµÄ½á¹¹ 3. ½üÄêÀ´ÔÚÖ×ÁöÃâÒßÑо¿ÁìÓòÖÐÓÐÄÄÐ©ÖØÒª½øÕ¹?ÊÔÊöµ±Ç°Ìá¸ß»úÌ忹Ö×ÁöÃâÒßµÄÖ÷Òª²ßÂÔ¡£ !dh:jPpKq
r#&JfAo
Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(ÃâÒßѧרҵ) ÎÊ´ðÌâ(ÿÌâ25·Ö) 1ZYo-a;)
p>3QW3<
1. ÊԱȽÏTϸ°ûÊÜÌ壨TCR£©¡¢Bϸ°ûÊÜÌ壨BCR£©ºÍNKϸ°ûÊÜÌ壨NKCR£©µÄ×é³É£¬Ê¶±ðÅäÌåÒÔ¼°ÐźÅתµ¼µÄÒìͬµã¡£ M3F1O6=4j
} snS~kx
2. ÒÔÐØÏÙÒÀÀµ¿¹Ô´Ì¼¤»úÌå²úÉú¿¹ÌåµÄÃâÒßÓ¦´ðΪÀý£¬Tϸ°ûºÍBϸ°ûÊÇÈçºÎÏ໥×÷Óã¿ÓÐÄÄЩճ¸½·Ö×Ӻ͹²´Ì¼¤·Ö×Ó²ÎÓëT¡¢Bϸ°ûµÄÏ໥×÷Óã¿ ~!g2+^G7+P
UHU ,zgM
3. Éö×ÛºÏÕ÷³öѪÈÈ(HFRS)²¡¶¾µÄ½á¹¹»ùÒòÒѾ¸ãÇå³þ,ΪÁË֤ʵHFRS²¡¶¾¸ÐȾ»úÌå(ÒÔBalb/CСÊóΪÀý)¿É²úÉúHFRS²¡¶¾ºËÒ¿ǵ°°×(NP)ÌØÒìÐÔCTL,²¢ÔÚÃâÒß·À»¤ÖÐÆðÖØÒª×÷ÓÃ,ÇëÓ¦ÓÃÃâÒßѧÀíÂۺͷ½·¨,Éè¼ÆÒ»ÏµÍ³ÊµÑé,¼ÓÒÔ֤ʵ¡£ 4. Àý¾Ù¶þ¸ö½üÄêÀ´Ï¸°ûºÍ·Ö×ÓÃâÒßѧÑо¿ÖгöÏÖµÄеÄÈȵã,Çë·Ö±ðÆÀÊöÆäÑо¿ÒâÒå¡¢·¢Õ¹Ç÷ÊÆÒÔ¼°Ó¦ÓÃǰ¾°¡£